MYASTHENIA GRAVIS (MG)
Clinical trials for MYASTHENIA GRAVIS (MG) explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS (MG) trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS (MG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy targets devastating autoimmune diseases that resist standard treatments
Disease control Recruiting nowThis is an early-stage study testing a new cell therapy called EVM18001 for people with severe, hard-to-treat autoimmune diseases: lupus, scleroderma, and myasthenia gravis. The main goal is to check if the treatment is safe and to find the right dose. Researchers will also look …
Matched conditions: MYASTHENIA GRAVIS (MG)
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
One-Shot cell therapy aims to reset immune system in devastating brain diseases
Disease control Recruiting nowThis early-stage study is testing a new, 'off-the-shelf' CAR-T cell therapy called RD06-05 in adults with severe, hard-to-treat neurological autoimmune diseases like multiple sclerosis and myasthenia gravis. The goal is to see if a single infusion of these engineered immune cells…
Matched conditions: MYASTHENIA GRAVIS (MG)
Phase: EARLY_PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC